A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC
Clinical trial NCT05884398 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05884398
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2026-10-12
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.